<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>lopinavir ritonavir</title><link>http://www.unboundmedicine.com/medline/ebm/research/lopinavir_ritonavir</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890203/full_citation/The_protease_inhibitor_combination_lopinavir/ritonavir_does_not_decrease_insulin_secretion_in_healthy_HIV_seronegative_volunteers_</link><description>Pao VY, Lee GA, Taylor S, et al. <br/><span class="title">The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS (London, England)">AIDS 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890203/abstract/The_protease_inhibitor_combination_lopinavir/ritonavir_does_not_decrease_insulin_secretion_in_healthy_HIV_seronegative_volunteers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890203/full_citation/The_protease_inhibitor_combination_lopinavir/ritonavir_does_not_decrease_insulin_secretion_in_healthy_HIV_seronegative_volunteers_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0269-9370%26amp;volume=%26amp;issue=%26amp;spage=">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890203/The_protease_inhibitor_combination_lopinavir/ritonavir_does_not_decrease_insulin_secretion_in_healthy_HIV_seronegative_volunteers_">Find Related Articles</a> </description></item><item><title>Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_</link><description>Quaranta S, Woloch C, Paccou A, et al. <br/><span class="title">Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/abstract/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19865000/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Find Related Articles</a> </description></item><item><title>Trends in uptake of recently approved antiretrovirals within a national healthcare system.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19863620/full_citation/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_</link><description>Belperio P, Mole L, Boothroyd D, et al. <br/><span class="title">Trends in uptake of recently approved antiretrovirals within a national healthcare system. [JOURNAL ARTICLE]</span><br/><span class="source" title="HIV medicine">HIV Med 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19863620/abstract/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19863620/full_citation/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19863620/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Find Related Articles</a> </description></item><item><title>THERAPEUTIC DRUG MONITORING OF LOPINAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING ADULT TABLETS: THERAPEUTIC DRUG MONITORING OF LOPINAVIR TABLETS GIVEN TO CHILDREN.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19858772/full_citation/THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_IN_HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTED_CHILDREN_RECEIVING_ADULT_TABLETS:_THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_TABLETS_GIVEN_TO_CHILDREN_</link><description>Puthanakit T, Chokephaibulkit K, Suntarattiwong P, et al. <br/><span class="title">THERAPEUTIC DRUG MONITORING OF LOPINAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING ADULT TABLETS: THERAPEUTIC DRUG MONITORING OF LOPINAVIR TABLETS GIVEN TO CHILDREN. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Oct 24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19858772/abstract/THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_IN_HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTED_CHILDREN_RECEIVING_ADULT_TABLETS:_THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_TABLETS_GIVEN_TO_CHILDREN_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19858772/full_citation/THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_IN_HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTED_CHILDREN_RECEIVING_ADULT_TABLETS:_THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_TABLETS_GIVEN_TO_CHILDREN_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19858772/THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_IN_HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTED_CHILDREN_RECEIVING_ADULT_TABLETS:_THERAPEUTIC_DRUG_MONITORING_OF_LOPINAVIR_TABLETS_GIVEN_TO_CHILDREN_">Find Related Articles</a> </description></item><item><title>Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19842932/full_citation/Association_between_ABCC2_polymorphism_and_lopinavir_accumulation_in_peripheral_blood_mononuclear_cells_of_HIV_infected_patients_</link><description>Elens L, Yombi JC, Lison D, et al. <br/><span class="title">Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients. [Journal Article]</span><br/><span class="source" title="Pharmacogenomics">Pharmacogenomics 2009 Oct; 10(10):1589-97.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19842932/abstract/Association_between_ABCC2_polymorphism_and_lopinavir_accumulation_in_peripheral_blood_mononuclear_cells_of_HIV_infected_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19842932/full_citation/Association_between_ABCC2_polymorphism_and_lopinavir_accumulation_in_peripheral_blood_mononuclear_cells_of_HIV_infected_patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19842932/Association_between_ABCC2_polymorphism_and_lopinavir_accumulation_in_peripheral_blood_mononuclear_cells_of_HIV_infected_patients_">Find Related Articles</a> </description></item><item><title>High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19838128/full_citation/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_</link><description>Fox MP, Ive P, Long L, et al. <br/><span class="title">High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Oct 15.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19838128/abstract/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19838128/full_citation/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19838128/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Find Related Articles</a> </description></item><item><title>Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19835489/full_citation/Voriconazole_use_and_pharmacokinetics_in_combination_with_interferon_gamma_for_refractory_cryptococcal_meningitis_in_a_patient_receiving_low_dose_ritonavir_</link><description>Nierenberg NE, Thompson GR, Lewis JS, et al. <br/><span class="title">Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medical mycology : official publication of the International Society for Human and Animal Mycology">Med Mycol 2009 Oct 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19835489/abstract/Voriconazole_use_and_pharmacokinetics_in_combination_with_interferon_gamma_for_refractory_cryptococcal_meningitis_in_a_patient_receiving_low_dose_ritonavir_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19835489/full_citation/Voriconazole_use_and_pharmacokinetics_in_combination_with_interferon_gamma_for_refractory_cryptococcal_meningitis_in_a_patient_receiving_low_dose_ritonavir_">Full Citation</a></description></item><item><title>TWIN PRETERM NEONATES WITH CARDIAC TOXICITY RELATED TO LOPINAVIR/RITONAVIR THERAPY.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19820426/full_citation/TWIN_PRETERM_NEONATES_WITH_CARDIAC_TOXICITY_RELATED_TO_LOPINAVIR/RITONAVIR_THERAPY_</link><description>McArthur MA, Kalu SU, Foulks AR, et al. <br/><span class="title">TWIN PRETERM NEONATES WITH CARDIAC TOXICITY RELATED TO LOPINAVIR/RITONAVIR THERAPY. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Oct 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19820426/abstract/TWIN_PRETERM_NEONATES_WITH_CARDIAC_TOXICITY_RELATED_TO_LOPINAVIR/RITONAVIR_THERAPY_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19820426/full_citation/TWIN_PRETERM_NEONATES_WITH_CARDIAC_TOXICITY_RELATED_TO_LOPINAVIR/RITONAVIR_THERAPY_">Full Citation</a></description></item><item><title>Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19812439/full_citation/Virological_and_immunological_responses_to_efavirenz_or_boosted_lopinavir_as_first_line_therapy_for_patients_with_HIV_</link><description>Young J, Bucher HC, Guenthard HF, et al. <br/><span class="title">Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antiviral therapy">Antivir Ther 2009; 14(6):771-779.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19812439/abstract/Virological_and_immunological_responses_to_efavirenz_or_boosted_lopinavir_as_first_line_therapy_for_patients_with_HIV_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19812439/full_citation/Virological_and_immunological_responses_to_efavirenz_or_boosted_lopinavir_as_first_line_therapy_for_patients_with_HIV_">Full Citation</a></description></item><item><title>Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19807276/full_citation/Pharmacokinetic_Evaluation_of_Rifabutin_in_Combination_with_Lopinavir_Ritonavir_in_Patients_with_HIV_Infection_and_Active_Tuberculosis_</link><description>Boulanger C, Hollender E, Farrell K, et al. <br/><span class="title">Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Oct 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19807276/abstract/Pharmacokinetic_Evaluation_of_Rifabutin_in_Combination_with_Lopinavir_Ritonavir_in_Patients_with_HIV_Infection_and_Active_Tuberculosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19807276/full_citation/Pharmacokinetic_Evaluation_of_Rifabutin_in_Combination_with_Lopinavir_Ritonavir_in_Patients_with_HIV_Infection_and_Active_Tuberculosis_">Full Citation</a></description></item></channel></rss>